Clinical Trial Update: Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update describes evaluating PD-1 inhibition with neoadjuvant proton or photon radiation therapy for recurrent head and neck squamous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: University of Cincinnati | Conditions: Head and Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING